Oxford-astrazeneca Vaccine

Future pandemics could be more lethal than COVID-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it is prepared for the next viral onslaught, one of the creators of the Oxford-AstraZeneca vaccine said.

People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study.

There aren't many places left for the COVID-19 virus to mutate and evade immunity as it will only get weaker with time, said the creator of the Oxford-AstraZeneca vaccine, the most widely distributed jab in the world.

Although it is the same as the Oxford-AstraZeneca vaccine used in the UK's immunisation programme, Covishield wasn't approved until now. But the problem, the British envoy in India said, is India isn't on the 'green list' as Covid cases remain here.

The Oxford-AstraZeneca vaccine, also known as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK.

The scientific committee overseeing Britain's coronavirus vaccination programme on Friday recommended that under-40s are offered an alternative to the Oxford-AstraZeneca Covid jab.

A large study in Denmark and Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first dose of the Oxford-AstraZeneca COVID-19 vaccine.

Punjab Chief Minister Amarinder Singh on Sunday directed the health department to order 30 lakh doses of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from the Serum Institute of India for vaccination of the 18-45 age group.

The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.

The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.

The Drugs Controller General of India or DCGI, India's drug regulator, has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date.

Covishield is safe and there is "no signal of concern" regarding it as of now, the Centre asserted on Wednesday amid reports of possible side-effects of the Oxford-AstraZeneca's COVID-19 vaccine and its suspension in some European countries.

There is no signal of concern regarding the use of Oxford-AstraZeneca COVID-19 vaccine in the country, said Member (Health) of the Niti Aayog Dr VK Paul, amid speculations and subsequent review of possible side-effects of the vaccine in different countries.

Brazil has ordered 100 million doses of the Pfizer-BioNTech Covid-19 vaccine and another 38 million of Johnson & Johnson's, the health minister said Monday, seeking to accelerate the hard-hit country's lagging immunization campaign.

The UK government on Thursday defended the Oxford-AstraZeneca Covid-19 vaccine after Denmark suspended the jab's use, and insisted it would continue with its own rollout.

Future pandemics could be more lethal than COVID-19 so the lessons learned from the outbreak must not be squandered and the world should ensure it is prepared for the next viral onslaught, one of the creators of the Oxford-AstraZeneca vaccine said.

People who received a first dose of the Oxford-AstraZeneca COVID-19 vaccine followed by an mRNA vaccine shot had a lower risk of infection compared to those immunised with both doses of the AstraZeneca preventive, according to a nationwide study.

There aren't many places left for the COVID-19 virus to mutate and evade immunity as it will only get weaker with time, said the creator of the Oxford-AstraZeneca vaccine, the most widely distributed jab in the world.

Although it is the same as the Oxford-AstraZeneca vaccine used in the UK's immunisation programme, Covishield wasn't approved until now. But the problem, the British envoy in India said, is India isn't on the 'green list' as Covid cases remain here.

The Oxford-AstraZeneca vaccine, also known as Covishield, may be associated with a very small risk of developing a blood condition characterised by low platelet counts, according to a nationwide study in the UK.

The scientific committee overseeing Britain's coronavirus vaccination programme on Friday recommended that under-40s are offered an alternative to the Oxford-AstraZeneca Covid jab.

A large study in Denmark and Norway has found slightly increased rates of vein blood clots, including in the brain, among adults who had received their first dose of the Oxford-AstraZeneca COVID-19 vaccine.

Punjab Chief Minister Amarinder Singh on Sunday directed the health department to order 30 lakh doses of Oxford-AstraZeneca COVID-19 vaccine, Covishield, from the Serum Institute of India for vaccination of the 18-45 age group.

The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.

The UK medical regulator said Saturday that out of 30 people who suffered rare blood clots after receiving the Oxford-AstraZeneca vaccine, seven have died.

The Drugs Controller General of India or DCGI, India's drug regulator, has extended the shelf life of Covishield, the Oxford-AstraZeneca COVID-19 vaccine, from six to nine months from its manufacturing date.

Covishield is safe and there is "no signal of concern" regarding it as of now, the Centre asserted on Wednesday amid reports of possible side-effects of the Oxford-AstraZeneca's COVID-19 vaccine and its suspension in some European countries.

There is no signal of concern regarding the use of Oxford-AstraZeneca COVID-19 vaccine in the country, said Member (Health) of the Niti Aayog Dr VK Paul, amid speculations and subsequent review of possible side-effects of the vaccine in different countries.

Brazil has ordered 100 million doses of the Pfizer-BioNTech Covid-19 vaccine and another 38 million of Johnson & Johnson's, the health minister said Monday, seeking to accelerate the hard-hit country's lagging immunization campaign.

The UK government on Thursday defended the Oxford-AstraZeneca Covid-19 vaccine after Denmark suspended the jab's use, and insisted it would continue with its own rollout.